Skip to content
Institutional Investor middle-market control private equity buyouts (founder-owned PE-backed corporate divestitures) Est. 1983

ORIX Capital Corporation

VC firm investing primarily in Japan

📍 Tokyo, Japan
Website ↗

About This Fund

ORIX Capital is a venture capital investment company. Geographies of interest include Japan. Invests in multiple sectors like Biopharma, Gaming, Manufacturing and Drug Discovery. Top investments include REGiMMUNE, UMN Pharma, Shannon, Edia.

Investment Focus

Sectors
business services industrial services automation solutions environmental services infrastructure & utility services marketing services telecom services
Stages
middle-market control private equity buyouts (founder-owned PE-backed corporate divestitures)
Check Size $75M-$250M equity
Geography
USA

What They Look For

North America; EBITDA $10M-$75M; profitable scalable businesses in fragmented asset-light industries; strong organic/inorganic growth potential, differentiated products/services, excellent leadership, positive culture, strong customer relationships

Related Funds

Browse all funds →

Preparing to pitch ORIX Capital Corporation?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →